334 related articles for article (PubMed ID: 26352674)
1. Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4.
Madadi NR; Penthala NR; Howk K; Ketkar A; Eoff RL; Borrelli MJ; Crooks PA
Eur J Med Chem; 2015 Oct; 103():123-32. PubMed ID: 26352674
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4.
Mur Blanch N; Chabot GG; Quentin L; Scherman D; Bourg S; Dauzonne D
Eur J Med Chem; 2012 Aug; 54():22-32. PubMed ID: 22647220
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
11. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
[TBL] [Abstract][Full Text] [Related]
12. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
[TBL] [Abstract][Full Text] [Related]
14. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
Barnes NG; Parker AW; Ahmed Mal Ullah AA; Ragazzon PA; Hadfield JA
Bioorg Med Chem; 2020 Oct; 28(19):115684. PubMed ID: 32912434
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues.
Elagawany M; Schmitt M; Ghiaty A; El-Etrawy ASh; Ibrahim MA; Bihel F; Sbardelotto AB; Pessoa C; Nguyen TL; Hamel E; Bourguignon JJ
Anticancer Agents Med Chem; 2013 Sep; 13(7):1133-40. PubMed ID: 23574386
[TBL] [Abstract][Full Text] [Related]
16. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry.
Pagliai F; Pirali T; Del Grosso E; Di Brisco R; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Jan; 49(2):467-70. PubMed ID: 16420033
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of pyrrole analogues of combretastatin A-4.
Jung EK; Leung E; Barker D
Bioorg Med Chem Lett; 2016 Jul; 26(13):3001-3005. PubMed ID: 27212068
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
[TBL] [Abstract][Full Text] [Related]
20. Photoresponsive azo-combretastatin A-4 analogues.
Rastogi SK; Zhao Z; Barrett SL; Shelton SD; Zafferani M; Anderson HE; Blumenthal MO; Jones LR; Wang L; Li X; Streu CN; Du L; Brittain WJ
Eur J Med Chem; 2018 Jan; 143():1-7. PubMed ID: 29172077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
